WALGREEN COMPANY

Lobbying for WALGREEN COMPANY

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Expenses

$770,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 2484
Seniors’ Access to Critical Medications Act of 2025

Lobbying activity 3

Consumer Issues/Safety/Products

- Issues related to preventing organized retail crime

Taxation/Internal Revenue Code

- Issues related to tax reform

Pharmacy

- Issues related to access to pharmacist services - Issues related to increasing participation and diversity in clinical trials - Issues related to pharmacy benefit managers - H.R. 2484: Seniors Critical Access to Medications Act; issues related to pharmacist services - Issues related to 340B - Issues related to vaccine access

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.